Navigation Links
Elsevier's EMBASE.com Partners With QUOSA
Date:12/1/2008

ate from citations to full text from the world's leading scientific, technical and medical (STM} publishers.

"The integration of EMBASE.com as a channel for use with the QUOSA Information Manager and Virtual Library literature management application has been invaluable in our development of a Medical eLibrary Services group," according to Amyas Huston, Senior Manager Medical Communications, Cubist Pharmaceuticals, Inc. "The combined functionality allows our group to conduct searches against both the EMBASE and MEDLINE bibliographic databases, retrieve selected articles and provide a literature document repository for copyright-compliant web-based access of publications to internal colleagues."

Used extensively by the pharmaceutical industry, EMBASE.com retrieves information to support such tasks as: new drug development and discovery of new applications for existing drugs, drug safety and pharmacovigilance procedures, legislative and regulatory compliance, clinical trial program management, PI/Supplementary Protection Certificates and IB writing and regulatory filing documentation such as New Drug Applications (NDAs).

"We are very pleased to have added EMBASE.com to our supported channels, following on from our earlier support of Scopus," says Malcolm MacKenzie, President of QUOSA. "EMBASE.com users can now benefit from the full power of our literature workflow solution, serving not only the information specialist's own needs, but also providing superior current awareness and literature management for project teams and the wider organization."

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering
'/>"/>

SOURCE Elsevier
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
2. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
3. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
4. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
5. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
7. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
8. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
9. AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference
10. Tutogen Medical, Inc. to Present at the Roth Capital Partners 2007 New York Conference
11. Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... (PRWEB) May 21, 2013 The Formulate ... display solution for sales and marketing teams looking for a ... describes the kit as “everything you’ll need to put together ... Display Kit comes with a number of displays and accessories ... booth 20 feet by 20 feet in size. These components ...
(Date:5/20/2013)... 20, 2013 Oven Industries Inc. announces ... capabilities. The 5R6-900 benchtop controller has many outstanding user-friendly ... be plugged into the wall as a self-contained temperature ... distinctive detail makes the device unique, as well as ... temperature controller can also be used universally, which allows ...
(Date:5/20/2013)...  Dr. Gerald Zon , noted ... launched a new blog in conjunction with TriLink BioTechnologies. ... focuses on what,s trending in the field of nucleic ... discussions of research presented at conferences and meetings, reviews ... Zon (PhD Princeton University 1971) developed automated synthesis of ...
(Date:5/20/2013)... , May 20, 2013 Cempra, ... on developing differentiated antibiotics to meet critical medical ... announced that it presented data at the American ... Philadelphia demonstrating the antibacterial and ... Cempra,s prior Phase 2 clinical trial in outpatients ...
Breaking Biology Technology:GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2New Laboratory Temperature Controller by Oven Industries 2Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2
... 2011 iBio, Inc. (NYSE AMEX: ... the United States Patent and Trademark Office for US ... Plants," that further extends iBio,s patent coverage of viral ... by iBio was developed by scientists at iBio,s research ...
... WEST LAFAYETTE, Ind. - The merging of two technologies ... the emergence of new "quantum information systems" far more ... using single photons the tiny particles that make up ... might harness the exotic principles of quantum mechanics. ...
... Mont., Oct. 28, 2011 /PRNewswire/ -- Bacterin International Holdings, ... the development of revolutionary bone graft material and antimicrobial coatings ... Parade® Float entitled "...One More Day." Bacterin ... family to attend the Rose Parade and will be recognized ...
Cached Biology Technology:iBio Announces New US Patent for iBioLaunch™ Technology 2iBio Announces New US Patent for iBioLaunch™ Technology 3New hybrid technology could bring 'quantum information systems' 2Bacterin Sponsors the 2012 Donate Life Rose Parade Float in Recognition of Donor Families 2Bacterin Sponsors the 2012 Donate Life Rose Parade Float in Recognition of Donor Families 3
(Date:5/20/2013)... the antibiotic colistin are also commonly resistant to ... to a study in mBio , the ... Microbiology. Cross-resistance to colistin and host antimicrobials LL-37 ... bacterial attack, could mean that patients with life-threatening ... crippled immune response. Colistin is a last-line drug ...
(Date:5/20/2013)... planning grant will help establish the Center for Advanced ... University of Illinois at Urbana-Champaign and Worcester Polytechnic Institute ... to research in drying moist, porous materials such as ... chemical products; textiles; and biopharmaceuticals," said Hao Feng, a ... nutrition and the Illinois site director. , According to ...
(Date:5/19/2013)... a strain of electricity-producing bacteria that can grow using ... dioxide as its sole source of carbon. Researchers ... at the 113th General Meeting of the American Society ... current production solely on hydrogen," says Amit Kumar, a ... are part of the Lovley Lab Group at the ...
Breaking Biology News(10 mins):Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3NSF approves planning grant for Center for Advanced Research in Drying 2
... Knowing how trees grow and how they age may ... warmer climate, for instance, and other changes. Little is known, ... tree growth. "Although much research has been done on how ... increase in size," says research ecologist Frederick (Rick) Meinzer, "structure ...
... a new journal in systematic and biology of fungi ... the new journal is Dr Thorsten Lumbsch from The Field Museum, Chicago ... published open access and is free to read, download, print, and distribute. ... journals ZooKeys and PhytoKeys . ...
... release is available in German . They live their ... an upright position, sloths spend most of their lives hanging in ... only slowly. Very slowly. But why are sloths so ,lazy,? And ... unhurried lifestyle in the course of evolution? Zoologists of the Friedrich ...
Cached Biology News:Pensoft Publishers launch a new mycological open-access journal 2Pensoft Publishers launch a new mycological open-access journal 3The decoding of slowness 2
...
...
Mouse monoclonal antibody raised against a partial recombinant ALAS2. NCBI Entrez Gene ID = ALAS2...
Mouse monoclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = QPCT...
Biology Products: